PMAT variant rs3889348 is associated with metformin-induced gastrointestinal among Chinese Type 2 diabetes patients

Author:

Liu Ziqing1ORCID,Jia Xiao2ORCID,Wu Peng3ORCID,Wu Benrui14,Pan Ying5,Zhong Shao5,Xiao Luhua6,Song Yuehong7,Hu Jinbo8,Zhou Kaixin3

Affiliation:

1. College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 10140, China

2. State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy & Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300000, China

3. Guangzhou Laboratory, Guangdong Province, China

4. National Laboratory of Biomacromolecules, Institute of Biophysics Chinese Academy of Sciences, Beijing, 100101, China

5. The first people's hospital of Kunshan, Jiangsu Province, China

6. Kunshan community health service center in Bailu, Jiangsu Province, China

7. Kunshan community health service center in Zhenchuan, Jiangsu Province, China

8. Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Abstract

Aim: This study examined intronic gene variants for their association with metformin intolerance in a Chinese population, focusing on the plasma monoamine transporter ( PMAT) cis-protein expression quantitative trait loci (cis-eQTL) variant rs3889348. Methods: We recruited Type 2 diabetes patients from two hospitals and identified 111 metformin-intolerant patients using a questionnaire, and selected 206 metformin-tolerant patients from 2180 Type 2 diabetes mellitus patients. Genetic testing revealed an association between adverse gastrointestinal (GI) effects and SLC22A1 and PMAT. Results: The single-nucleotide polymorphism rs3889348 is associated with metformin-induced adverse GI effects. Each additional copy of the G allele increases the score by 5.23 (95% CI: 1.82–8.64; p = 0.003). Patients taking more transporter inhibitors were more likely to respond to metformin-induced GI intolerance (p = 0.042). Conclusion: PMAT cis-eQTL rs3889348 was significantly associated with metformin-induced adverse GI effects.

Funder

The 2020 Suzhou Science and Technology Development Plan Project

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3